Loestrin 24 Fe, Minastrin 24 Fe Antitrust Settlement

Settlement Structure: Claims Made

Active: Open

Case Summary:

This antitrust case has a long list of defendants, including companies related to Lupin, Warner Chilcott, and Watson. The complaint was filed by a group of end-payors who claimed that the companies violated antitrust laws and engaged in anticompetitive behavior by conspiring to keep generic versions of Loestrin 24 Fe and Minastrin 24 Fe off the market. This caused consumers and third-party payors to pay too much for these contraceptives.

Docket Number:

1:13-md-02472

Company: Lupin Ltd.

Filing Deadline: September 21, 2020

Class Period: September 1, 2009 to May 2, 2019

Objection Deadline: June 22, 2020

Exclusion Deadline: June 22, 2020

Final Approval Hearing: August 27, 2020

Proof of Purchase:

If the total net amount of your claim is more than $300,000, you must submit claims data and information supporting the amount. If your total net claim is $300,000 or less, you do not need to provide complete data with your claims form, but the settlement administrator may ask for supporting documentation.

Eligibility:

You may be eligible if you belonged to one of the two groups below between September 1, 2009 and May 2, 2019.

Consumer: You bought or paid some or all of the purchase price for Loestrin 24 Fe, Minastrin 24 Fe, or generic versions of these drugs, for consumption by yourself or your family members, not for resale, in the US and its territories, including Puerto Rico.

Third-Party Payor (TPP): You bought, paid, or provided reimbursement for some of all of the purchase price for Loestrin 24 Fe, Minastrin 24 Fe, or generic versions of these drugs, for consumption by your members, employees, insured, participants, or beneficiaries, and not for resale, in the US and its territories, including Puerto Rico.

Typical Settlement Amount:

Varies. Warner Chilcott Settlement: No payments to consumers. TPP that submit valid claims will receive payments based on various factors, including the number of valid claims filed by all TPP class members and the dollar value of each claimant’s purchase. Lupin Settlement: Because of the costs of the litigation and settlement, there will likely not be sufficient funds to compensate consumer class members. TPPs must submit valid claim forms.

Total Settlement Amount: $63,500,000

Class Representative Proposed Incentive Fee:

Up to $10,000 for TPP class representatives; $5,000 for consumer named plaintiffs in the Lupin Settlement Class.

Law Firms:
Cohen Milstein Sellers & Toll
Hilliard & Shadowen LLP
Miller Law LLC
Motley Rice LLC

Claim Form: Loestrin 24 Fe, Minastrin 24 Fe Antitrust Settlement Claim Form

Case Name: In re Loestrin Fe Antitrust Litigation

Settlement Website: Loestrin 24 Fe, Minastrin 24 Fe Antitrust Settlement Website

Claims Administrator:
AB Data, Ltd.a

Claims Administrator Contact Information:

In re Loestrin 24 Fe Antitrust Litigation
c/o A.B. Data Ltd.
P.O. Box 173085
Milwaukee, WI 53217
1-877-324-0380
info@InReLoestrin24FEAntitrustLitigation.com

Tags: Antitrust, Pharmaceuticals